Arkolith/Insider Trading/ENOB/Form 4

Sindlev Rene

Director, 10% OwnerEnochian Biosciences Inc (ENOB) · full profile →Form 4 · filed May 20, 2022
Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2022Buy(P)125K$8.00$1.0M125K
May 18, 2022Buy(P)128K$8.00$1.0M128K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-22-000958) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML